Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Pagonabarraga, Javier, Martinez‐Horta, Saul, Fernández de Bobadilla, Ramón, Pérez, Jesús, Ribosa‐Nogué, Roser, Marín, Juan, Pascual‐Sedano, Berta, García, Carmen +2 more·2016·Movement Disorders
DOI 10.1002/mds.26432

Cited by (237)

Items 201–237 of 237

  1. Risk Factors for Psychosis in Parkinson’s Disease
    Matthew J. Barrett · 2017 · US Endocrinology
  2. Understanding the temporal dynamics of visual hallucinations in Parkinson's Disease with dementia
    Nicholas Murphy · 2016
  3. Risk Factors for Psychosis in Parkinson’s Disease
    Matthew J. Barrett · 2017 · touchREVIEWS in Neurology
  4. HALLUCINATION AND RISK FACTORS IN PATIENTS WITH PARKINSON’S DISEASE
    Bahar Say, Yasemin Ünal, Tuğba Tunç, Gülnihal Kutlu, Ufuk Ergün · 2019 · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
  5. Visual Misperceptions and Behavioral Variability in Parkinson’s Disease
    Krisitna Miloserdov · 2020
  6. Disturbances of visual perception in non-demented patients with Parkinson’s disease
    R. Timofejavaitė, V. Vilda, A LIVEIKIENE, Rūta Kaladytė Lokominienė · 2019 · Neurologijos seminarai
  7. Dementia with Lewy bodies and Parkinson’s disease dementia-two independent disorders or one clinical entity within a clinical spectrum of synucleinopathies?
    Ewa Papuć · 2020 · Current Problems of Psychiatry
  8. Neuropsychiatrische Störungen bei idiopathischem Parkinson-Syndrom
    Mario Paulig · 2021 · Nervenheilkunde
  9. Cariprazina como alternativa farmacológica en el tratamiento de la psicosis en la enfermedad de Parkinson
    Javier Vilches Vázquez, José Manuel Gallego Rodríguez · 2021 · Psiquiatría Biológica
  10. Allucinazioni e morbo di Parkinson
    Alice Poisson, Stéphane Thobois · 2022 · EMC - Neurologia
  11. Current Understanding of Psychosis in Parkinson's Disease☆
    X. Garcia, H.H. Fernandez · 2016 · Elsevier eBooks
  12. Motor and non-motor effects of apomorphine infusion
    Robbert W. K. Borgemeester · 2022
  13. Symptômes non moteurs dans la maladie de Parkinson
    Isabelle Bénatru · 2022 · Elsevier eBooks
  14. Clinical Features II
    Roger L. Albin · 2022
  15. Parkinson’s Disease and Atypical Parkinsonian Syndromes
    Julia G. Ridgeway‐Diaz, Laura Marsh · 2022
  16. Experiences of individuals with Parkinson’s disease who report sensed presence
    Richard Cant, Grace Devenney, Paddy Harris, Kimberley Hastings, Andrew James, Claire Morton, Natalie Salimi, Jacqueline Woods · 2020 · The Neuropsychologist
  17. Acute psychiatric problems in movement disorders
    Daniele Urso, Veria Vacchiano, Giovanni Rizzo, Giancarlo Logroscino · 2023 · International review of movement disorders
  18. Visual Impairments in Parkinson’s Disease
    A. Yu. Nikitina, N. V. Melnikova, Larisa Konstantinovna Moshetova, Oleg Semenovich Levin · 2023 · Neuroscience and Behavioral Physiology
  19. Avaliação morfológica e funcional da retina de pacientes com doença de Parkinson usando a tomografia de coerência óptica e o eletrorretinograma
    Luiz Guilherme Marchesi Mello · 2023
  20. Visual hallucinosis in patients with Parkinson’s disease
    A. Yu. Nikitina, N. V. Mel’nikova, Larisa Konstantinovna Moshetova, Oleg Semenovich Levin · 2024 · The Clinician
  21. Implicaciones reeducativas en la funcionalidad y calidad de vida de las personas con enfermedad de parkinson: implementación de una ortesis de tejido elastomérico dinámica
    María Jiménez Barrios · 2024
  22. Treatment Tactics for Psychosis in Parkinson’s Disease: A Literature Review
    Daiva Milmantienė · 2024 · Neurologijos seminarai
  23. Neuropsychiatric Manifestations in Parkinson Disease
    Daniel A. Weintraub, Julia Gallagher, Matthew Stern · 2025 · Cambridge University Press eBooks
  24. Psychometric properties of the Italian version of scale for outcomes in Parkinson’s disease psychiatric complications in Parkinson disease
    Sofia Cuoco, Arianna Cappiello, Immacolata Carotenuto, Maria Autuori, Rossella Bisogno, Cristiano Sorrentino, Marco Aiello, Paolo Barone, Marina Picillo · 2025 · Scientific Reports
  25. Metamorphopsia in a Male with Parkinson Disease: A Giant Problem?
    Eric Noyes, Natasha Gattey, Jenna Reding, Alex Rajput · 2025 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  26. Hallucinations in Parkinson’s Disease: What They Really Look Like and How They Affect the Quality of Life
    Ján Necpál, Milan Grofik, Michal Patarák, Bibiána Jeleňová, Viera Bebjaková, Lucia Baranová · 2025 · Bratislavské lekárske listy/Bratislava medical journal
  27. Visual misperceptions in favour of living beings in Parkinson's disease: A psychophysical study
    Laurent Cleret de Langavant, Aurore Mouton, Vincent de Gardelle, Sid Kouider, Anne‐Catherine Bachoud‐Lévi, Gilles Fénelon, Philippe Rémy · 2026 · Revue Neurologique
  28. Bases génétiques des troubles du contrôle des impulsions dans la maladie de Parkinson
    Samir Bekadar · 2021
  29. Temporal assessment of behavior in Parkinson’s visual hallucinations via a multidimensional analysis strategy
    Quan-Xin Zhang, Yi-Xuan Zhang, Chen-Chen Jiang, Jia-Wen Cheng, Shen-Jia Tao, Yunlong Pan, Fukunaga Kohji, Shu-Yang Chen, Xingfeng Mao, Li Zhang et al. · 2026 · Signal Transduction and Targeted Therapy
  30. True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's disease
    Joseph H. Friedman, Umer Akbar, Blake Beehler, Kelvin L. Chou, Leslie Jameleh Cloud, Andres Deik, Rebecca Gilbert, Stephen N. Gomperts, John L. Goudreau, Steven A. Gunzler et al. · 2026 · Arquivos de Neuro-Psiquiatria
  31. Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion : A preliminary study.
    角幸頼, 彩香 乳原, 裕二 尾関, Hiroshi Kadotani, Yukiyoshi Sumi, Ayaka Ubara, Yuji OZEKI · Institutional Repositories DataBase (IRDB)
  32. Parkinson’s disease beyond motor symptoms: a review of the validity and limitations of current classification of non-motor symptoms
    Asad Makhani, T. Mestre, Anne-Mary Abe · 2026 · Frontiers in Psychiatry
  33. Minor hallucinations as an early marker to differentiate dementia with Lewy bodies from Alzheimer's disease
    Marina Ruíz, Natàlia Pérez‐Carmona, Belén Piñol Ferrer, Ángel Pérez Sempere, Inmaculada Abellán Miralles · 2026 · Journal of Alzheimer s Disease
  34. Dopaminergic therapy selectively amplifies hallucination susceptibility in patients with Parkinson’s disease with cortico-striatal hyperconnectivity
    Fosco Bernasconi, Sara Stampacchia, Lucas Burget, Jevita Potheegadoo, Marie Elise Maradan‐Gachet, Sélim Habiby Alaoui, Sabina Catalano Chiuvé, Dimitri Van De Ville, Vanessa Fleury, Paul Krack et al. · 2026 · medRxiv
  35. Update on Parkinson’s Disease Psychosis: Epidemiology, Mechanisms and Management
    Caroline Kruse, Daniel A. Weintraub, John E. Duda, James F. Morley · 2026 · Neurology and Therapy
  36. Parkinson's disease-associated psychosis in a Brazilian sample: prevalence and clinical profile
    Henrique Nascimento Dourado, Isabelle Jacqueline Weber Oliveira, Camila Caroso Lobo, Gustavo Cavalcante Procópio, Ana Emanuela Coelho Pessoa Lima, Guilherme T. Valença · 2026 · Arquivos de Neuro-Psiquiatria
  37. Transdiagnostic mechanisms underlying non-affective psychosis: A role for hippocampal networks?
    Claire Kaplan, Kate Perepezko, Gregory M. Pontone, Arnold Bakker · 2026 · American Journal of Geriatric Psychiatry